AIM

AIM ImmunoTech Inc.
AIM

Overview Fund Activity

13 hedge funds and large institutions have $1.01M invested in AIM ImmunoTech Inc. in 2018 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
+1
Holders Change %
+8.33%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
2
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
SM
Sabby Management
Florida
$620K
2
UBS Group
UBS Group
Switzerland
$7K
3
Vanguard Group
Vanguard Group
Pennsylvania
$150K
4
Invesco
Invesco
Georgia
$4K

Top Sellers

1
Citadel Advisors
Citadel Advisors
Florida
$18K
2
TSS
Two Sigma Securities
New York
$0
3
GC
Guggenheim Capital
Illinois
$0
4
Bank of New York Mellon
Bank of New York Mellon
New York
$0
5
VF
Virtu Financial
New York
$10K
Name Holding Trade Value Shares
Change 		Shares
Change %
SM
1
Sabby Management
Florida
$620K +$620K +441 New
Vanguard Group
2
Vanguard Group
Pennsylvania
$150K +$4.25K +3 +3%
BlackRock
3
BlackRock
New York
$146K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$23K – – –
Citadel Advisors
5
Citadel Advisors
Florida
$18K -$45.7K -33 -72%
Creative Planning
6
Creative Planning
Kansas
$13K – – –
Northern Trust
7
Northern Trust
Illinois
$11K – – –
VF
8
Virtu Financial
New York
$10K -$1.43K -1 -13%
UBS Group
9
UBS Group
Switzerland
$7K +$7K +5 New
OAM
10
Occidental Asset Management
California
$5K – – –
Invesco
11
Invesco
Georgia
$4K +$4K +3 New
WPW
12
Waldron Private Wealth
Pennsylvania
$3K – – –
Royal Bank of Canada
13
Royal Bank of Canada
Ontario, Canada
$1K – – –
TSS
14
Two Sigma Securities
New York
– -$11K -7 Closed
GC
15
Guggenheim Capital
Illinois
– -$8K -4 Closed
Bank of New York Mellon
16
Bank of New York Mellon
New York
– -$4K -2 Closed